R.HuffJ.HasemanJ
doi: 10.3389/fendo.2024.1528457 Received 14 November 2024 Accepted 30 December 2024 Published 21 January 2025 Volume 15 - 2024 Edited by Claire Joanne Stocker, Aston University, United Kingdom Reviewed by Wael Sidrak, Abou Seifein Diabetes & Endocrine Center, Egypt Frederic Illouz, CHU Angers, France Christine Trapp, Connecticut Childrens Medical Center, United States Updates Copyright 2025 Koceva, Mleku Kozamernik, Jane, Herman, Ferjan and Jensterle
Plan participation remains a limiting factor, and wider uptake may require additional incentives or negotiation
Patients may start demanding these drugs without understanding who actually needs them, what the risks are, or whether they are even suitable for them
Ohhiras Probiotics Professional Formula$39.95 $129.95Price range: $39.95 through $129.95 RegActiv Essential ME-3$39.95